Sodium phenylbutyrate antagonizes prostate cancer through the induction of apoptosis and attenuation of cell viability and migration

BACKGROUND: Prostate cancer (PCa) is a leading cause of cancer-related death in men. Sodium phenylbutyrate (SPB) has shown its potential as an anticancer therapy in numerous cancer types. In the present study, we attempted to assess the effect of SPB against PCa and whether this treatment was associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yawen, Zheng, Shaobo, Chen, Binshen, Wen, Yong, Zhu, Shanwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869668/
https://www.ncbi.nlm.nih.gov/pubmed/27274278
http://dx.doi.org/10.2147/OTT.S101794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869668/
https://www.ncbi.nlm.nih.gov/pubmed/27274278
http://dx.doi.org/10.2147/OTT.S101794

Ejemplares similares